Comerica Securities’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.72M | Sell |
3,387
-1,823
| -35% | -$923K | 0.14% | 145 |
|
|
2023
Q2 | $2.72M | Sell |
5,210
-343
| -6% | -$179K | 0.19% | 119 |
|
|
2023
Q1 | $3.2M | Sell |
5,553
-717
| -11% | -$414K | 0.23% | 104 |
|
|
2022
Q4 | $3.45M | Sell |
6,270
-401
| -6% | -$221K | 0.25% | 106 |
|
|
2022
Q3 | $3.39M | Sell |
6,671
-199
| -3% | -$101K | 0.28% | 98 |
|
|
2022
Q2 | $3.73M | Sell |
6,870
-291
| -4% | -$158K | 0.28% | 94 |
|
|
2022
Q1 | $4.23M | Buy |
7,161
+79
| +1% | +$46.7K | 0.28% | 94 |
|
|
2021
Q4 | $4.73M | Sell |
7,082
-183
| -3% | -$122K | 0.3% | 85 |
|
|
2021
Q3 | $4.15M | Buy |
7,265
+137
| +2% | +$78.3K | 0.29% | 94 |
|
|
2021
Q2 | $3.6M | Buy |
7,128
+404
| +6% | +$204K | 0.27% | 95 |
|
|
2021
Q1 | $3.07M | Buy |
6,724
+215
| +3% | +$98.2K | 0.23% | 106 |
|
|
2020
Q4 | $3.03M | Sell |
6,509
-23
| -0.4% | -$10.7K | 0.24% | 97 |
|
|
2020
Q3 | $2.89M | Sell |
6,532
-267
| -4% | -$118K | 0.26% | 91 |
|
|
2020
Q2 | $2.47M | Buy |
6,799
+379
| +6% | +$137K | 0.23% | 100 |
|
|
2020
Q1 | $1.82M | Buy |
6,420
+280
| +5% | +$79.5K | 0.21% | 115 |
|
|
2019
Q4 | $2M | Buy |
6,140
+320
| +5% | +$104K | 0.19% | 126 |
|
|
2019
Q3 | $1.7M | Buy |
5,820
+1,149
| +25% | +$335K | 0.18% | 133 |
|
|
2019
Q2 | $1.37M | Buy |
4,671
+514
| +12% | +$151K | 0.15% | 148 |
|
|
2019
Q1 | $1.14M | Sell |
4,157
-1,397
| -25% | -$383K | 0.13% | 165 |
|
|
2018
Q4 | $1.24M | Buy |
5,554
+34
| +0.6% | +$7.62K | 0.16% | 144 |
|
|
2018
Q3 | $1.35M | Sell |
5,520
-243
| -4% | -$59.3K | 0.16% | 155 |
|
|
2018
Q2 | $1.2M | Sell |
5,763
-27
| -0.5% | -$5.6K | 0.14% | 178 |
|
|
2018
Q1 | $1.2M | Sell |
5,790
-381
| -6% | -$78.7K | 0.15% | 173 |
|
|
2017
Q4 | $1.17M | Buy |
6,171
+136
| +2% | +$25.9K | 0.15% | 172 |
|
|
2017
Q3 | $1.14M | Buy |
6,035
+448
| +8% | +$84.8K | 0.16% | 164 |
|
|
2017
Q2 | $976K | Buy |
5,587
+115
| +2% | +$20.1K | 0.15% | 176 |
|
|
2017
Q1 | $841K | Buy |
5,472
+1,395
| +34% | +$214K | 0.13% | 180 |
|
|
2016
Q4 | $575K | Buy |
4,077
+58
| +1% | +$8.18K | 0.24% | 109 |
|
|
2016
Q3 | $639K | Buy |
4,019
+1,277
| +47% | +$203K | 0.27% | 90 |
|
|
2016
Q2 | $405K | Buy |
2,742
+626
| +30% | +$92.5K | 0.2% | 113 |
|
|
2016
Q1 | $300K | Buy |
2,116
+381
| +22% | +$54K | 0.16% | 138 |
|
|
2015
Q4 | $246K | Sell |
1,735
-177
| -9% | -$25.1K | 0.15% | 154 |
|
|
2015
Q3 | $234K | Sell |
1,912
-431
| -18% | -$52.7K | 0.14% | 157 |
|
|
2015
Q2 | $304K | Sell |
2,343
-67
| -3% | -$8.69K | 0.08% | 252 |
|
|
2015
Q1 | $324K | Sell |
2,410
-181
| -7% | -$24.3K | 0.08% | 230 |
|
|
2014
Q4 | $325K | Sell |
2,591
-164
| -6% | -$20.6K | 0.21% | 94 |
|
|
2014
Q3 | $335K | Buy |
+2,755
| New | +$335K | 0.23% | 102 |
|